Dixie Esseltine
Impact in
- Hematology top 0.5%
- Multiple Myeloma Research and Treatments
- Oncology top 2%
- Peptidase Inhibition and Analysis
- Cancer Treatment and Pharmacology
- Bone health and treatments
Papers in
- Hematology 32
- Multiple Myeloma Research and Treatments 29
- Oncology 25
- Peptidase Inhibition and Analysis 10
- Cancer Treatment and Pharmacology 9
- Bone health and treatments 7
- Co-authors
- Paul G. Richardson (13 shared papers)Kenneth C. Anderson (11 shared papers)Bart Barlogie (8 shared papers)Sundar Jagannath (10 shared papers)James R. Berenson (5 shared papers)Seema Singhal (5 shared papers)David P. Schenkein (10 shared papers)Gordan Srkalović (3 shared papers)
- Journals
- Journal of Clinical Oncology (16 papers)Blood (7 papers)British Journal of Haematology (3 papers)Cancer (2 papers)Haematologica (2 papers)
- Partner nations
- United StatesItalyUnited Kingdom
In The Last Decade
Dixie Esseltine
44 papers receiving 3.0k citations
Peers
Comparison fields: 5 of 96
- Hematology 1.9k
- Oncology 1.6k
- Genetics 539
- Pathology and Forensic Medicine 506
- Molecular Biology 1.8k
Countries citing papers authored by Dixie Esseltine
This map shows the geographic impact of Dixie Esseltine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dixie Esseltine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dixie Esseltine more than expected).
Fields of papers citing papers by Dixie Esseltine
This network shows the impact of papers produced by Dixie Esseltine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dixie Esseltine. The network helps show where Dixie Esseltine may publish in the future.
Co-authors
The 25 scholars most cited alongside Dixie Esseltine, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 480 | |
| 2 | 2004 | 461 | |
| 3 | 2004 | 372 | |
| 4 | 2010 | 312 | |
| 5 | 2009 | 187 | |
| 6 | 2005 | 169 | |
| 7 | 2005 | 146 | |
| 8 | Bortezomib in combination with dexamethasone for the treatment of patients with relapsed and/or refractory multiple myeloma with less than optimal response to bortezomib alone. | 2006 | 123 |
| 9 | 2006 | 113 | |
| 10 | 2005 | 93 | |
| 11 | 2005 | 82 | |
| 12 | 2006 | 71 | |
| 13 | 1997 | 48 | |
| 14 | 2010 | 45 | |
| 15 | 2006 | 37 | |
| 16 | 2006 | 36 | |
| 17 | 1998 | 36 | |
| 18 | 2014 | 35 | |
| 19 | 2009 | 28 | |
| 20 | 2007 | 27 |
About Dixie Esseltine
Dixie Esseltine is a scholar working on Hematology, Oncology, Molecular Biology, Immunology and Genetics, having authored 44 papers that have together received 3.1k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (29 papers), Protein Degradation and Inhibitors (12 papers), Peptidase Inhibition and Analysis (10 papers), Ubiquitin and proteasome pathways (10 papers), Cancer Treatment and Pharmacology (9 papers), Bone health and treatments (7 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Lymphoma Diagnosis and Treatment (4 papers). The work is most often cited by research in Hematology (1.9k citations), Oncology (1.6k citations), Genetics (539 citations), Pathology and Forensic Medicine (506 citations) and Molecular Biology (1.8k citations). Dixie Esseltine has collaborated with scholars based in United States, Italy and United Kingdom. Frequent co-authors include Paul G. Richardson, Kenneth C. Anderson, Bart Barlogie, Sundar Jagannath, James R. Berenson, Seema Singhal, David P. Schenkein, Gordan Srkalović, Julian Adams and David Irwin. Their work appears in journals such as Journal of Clinical Oncology, Blood, British Journal of Haematology, Cancer and Haematologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.